Clinical Pathology Associates (CPA), a trusted leader in anatomic and clinical pathology services since 1948, announced its rebrand to Oculus Pathology in February 2025, marking a significant evolution in the organization’s identity.
This change reflects the company’s steadfast commitment to precision, partnership, and innovation, while also charting a course for the future of specialty pathology.
About about our rebrand
The Alternative to a Private Equity Buyout
With mergers and acquisitions holding strong in healthcare, especially among [...]
The Power of Pathology: How Oculus Pathology Drives Collaboration in Hospital Care
At Oculus Pathology, collaboration is more than [...]
